{"id":44873,"date":"2022-06-08T23:01:58","date_gmt":"2022-06-08T21:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/"},"modified":"2022-06-08T23:01:58","modified_gmt":"2022-06-08T21:01:58","slug":"medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/","title":{"rendered":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)"},"content":{"rendered":"
\n

ARLINGTON, Va.–(BUSINESS WIRE)–The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and Chief Executive Officer, effective July 20, 2022. Mr. Fish succeeds Pamela Goldberg who is stepping down after leading the organization for four years.\n<\/p>\n

<\/a><\/p>\n

\nMr. Fish joins MDIC following his most recent tenure as Executive Director, Center for Digital Health and Head of Sector Initiatives at AdvaMed, where he significantly expanded the association\u2019s digital health membership and scope of work while supporting the Center’s Executive Leadership Group. Previously, Mr. Fish served as the first Executive Director of AdvaMedDx, AdvaMed\u2019s corporate division focused on in vitro diagnostics, and subsequently as AdvaMed\u2019s Chief Strategy Officer, overseeing the association\u2019s global and domestic policy departments and providing thought leadership on the fast-evolving role of medical technology across all care delivery settings. Mr. Fish has demonstrated consistent success in developing effective public policies and achieving advocacy goals in numerous areas of healthcare regulation and delivery.\n<\/p>\n

\n\u201cOver the past several months the Board conducted an extensive search for a CEO with substantial experience in building and leading cross-sectional teams and a passion for medical device innovation. With his exceptional track record of leading and growing organizations with a commitment to advancing innovative patient care, Andrew is the ideal leader for MDIC as we continue to collaborate with our partners to advance science and enable transformational medical technology to shape the future,\u201d said MDIC Board Chairman Jijo James MD, Chief Medical Officer, MedTech and External Innovation at Johnson & Johnson.\n<\/p>\n

\n\u201cCDRH congratulates Andy Fish on his appointment as the new President and CEO of MDIC. We look forward to working with Andy and our continued collaboration and partnership with MDIC to support medical device safety and innovation in the interest of patient health,\u201d said Jeffrey Shuren MD, JD, Director, Center for Devices and Radiological Health (CDRH), FDA.\n<\/p>\n

\nMDIC, through its public-private partnership among government and regulatory agencies, nonprofits, and the medical device industry, aims to advance regulatory science and bring innovative technologies to patients. MDIC coordinates the development of methods, tools, and resources used in managing the medical device lifecycle to improve patient access to cutting-edge medical technology.\n<\/p>\n

\n\u201cBringing more than 20 years of experience in the industry, Andrew has the knowledge, expertise, and commitment to continue to build on MDIC\u2019s success that Pamela Goldberg helped to establish. Among other accomplishments, Pamela helped to launch of the Health Economics and Patient Value initiative to increase the utilization of real-world evidence in healthcare decision making. We are grateful for her leadership over the past four years,\u201d said James.\n<\/p>\n

\n\u201cAndy\u2019s service at AdvaMed over the past 12 years has prepared him very well to lead MDIC,\u201d said AdvaMed President and CEO Scott Whitaker. \u201cWhile we will miss Andy, we\u2019re glad to know he\u2019s not going too far\u2014MDIC has always been a great partner of AdvaMed\u2019s, given our shared mission to improve patient care, and we look forward to continuing that good work with MDIC under his leadership.\u201d\n<\/p>\n

\nIn accepting the position as Chief Executive Officer, Mr. Fish said, \u201cI am grateful for the opportunity to lead MDIC by serving as President and CEO. I look forward to bringing together medical devices and diagnostics stakeholders and leveraging our collective expertise, resources, and data to create new methods, tools, approaches, and standards that will assist in developing safe and effective medical technologies for patients everywhere.\u201d\n<\/p>\n

\nAbout the Medical Device Innovation Consortium<\/b>\n<\/p>\n

\nFounded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product lifecycle. MDIC\u2019s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http:\/\/www.mdic.org<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nGregory Bologna, MDIC
\n
AVP, Marketing and Communications
\n
gbologna@mdic.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ARLINGTON, Va.–(BUSINESS WIRE)–The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and Chief Executive Officer, effective July 20, 2022. Mr. Fish succeeds Pamela Goldberg who is stepping down after leading the organization for four years. Mr. Fish joins MDIC following his most recent tenure as Executive Director, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44873","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ARLINGTON, Va.–(BUSINESS WIRE)–The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and Chief Executive Officer, effective July 20, 2022. Mr. Fish succeeds Pamela Goldberg who is stepping down after leading the organization for four years. Mr. Fish joins MDIC following his most recent tenure as Executive Director, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-08T21:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)\",\"datePublished\":\"2022-06-08T21:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/\"},\"wordCount\":709,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220608006145\\\/en\\\/1481171\\\/21\\\/MDIC_10th_Anniv.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/\",\"name\":\"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220608006145\\\/en\\\/1481171\\\/21\\\/MDIC_10th_Anniv.jpg\",\"datePublished\":\"2022-06-08T21:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220608006145\\\/en\\\/1481171\\\/21\\\/MDIC_10th_Anniv.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220608006145\\\/en\\\/1481171\\\/21\\\/MDIC_10th_Anniv.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/","og_locale":"en_US","og_type":"article","og_title":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend","og_description":"ARLINGTON, Va.–(BUSINESS WIRE)–The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and Chief Executive Officer, effective July 20, 2022. Mr. Fish succeeds Pamela Goldberg who is stepping down after leading the organization for four years. Mr. Fish joins MDIC following his most recent tenure as Executive Director, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-08T21:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)","datePublished":"2022-06-08T21:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/"},"wordCount":709,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/","url":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/","name":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO) - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg","datePublished":"2022-06-08T21:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220608006145\/en\/1481171\/21\/MDIC_10th_Anniv.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medical-device-innovation-consortium-mdic-announces-andrew-fish-jd-appointed-as-president-and-chief-executive-officer-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44873"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44873\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}